Why EXEL? Exelixis, Inc. Analysis, Price & AI Insights | Whystock
EXEL
$43.68-0.78 (-1.75%)
Market ClosedLast close May 1
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.